| Drug Name |
Fludarabine phosphate |
| Drug ID |
BADD_D00915 |
| Description |
Fludarabine is a chemotherapeutic agent used in the treatment of hematological malignancies. It is commonly marketed under the brand name Fludara. |
| Indications and Usage |
For the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
L01BB05 |
| DrugBank ID |
DB01073
|
| KEGG ID |
D01907
|
| MeSH ID |
C042382
|
| PubChem ID |
30751
|
| TTD Drug ID |
D0TO2R
|
| NDC Product Code |
45963-621; 53183-7841; 59923-604; 51916-310; 33656-0015; 63323-192; 24201-237; 25021-242; 45963-609; 58623-0043; 59605-7136 |
| Synonyms |
fludarabine phosphate | fludarabine 5'-monophosphate | 9 beta-D-arabinofuranosyl-2-fluoroadenine monophosphate | fludarabine monophosphate | FaraAMP | fluoro-ara-AMP | 9H-purin-6-amine, 2-fluoro-9-(5-O-phosphono-beta-D-arabinofuranosyl)- | F-ara-AMP | NSC 312887 | NSC-312887 | Beneflur | Fludara |
